Pfizer and BioNTech to study enhanced Covid-19 vaccine candidate
The Phase 2 trial of BNT162b5 will enrol around 200 participants, aged between 18 and 55 years, who…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
28 Jul 22
The Phase 2 trial of BNT162b5 will enrol around 200 participants, aged between 18 and 55 years, who…
25 Jul 22
PH94B is designed to regulate the olfactory-amygdala neural circuits of fear and anxiety, but it did not achieve…
01 Jul 22
The US FDA has paused new enrolment in the US and told the participants who have been enrolled…
17 Jun 22
In the study, crenezumab did not slow or prevent cognitive decline in people with a specific genetic mutation…
13 Jun 22
The company’s investigational RSV vaccine candidate RSVPreF3 OA has showed statistically significant and clinically meaningful efficacy in adults…
31 May 22
Cialis is a PDE-5 inhibitor therapy that can be used to treat erectile dysfunction (ED), the signs and…
19 May 22
The Phase 1 clinical trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for…
12 May 22
The Phase 3 study evaluated the tiragolumab plus Tecentriq in 534 patients with first-line PD-L1-high metastatic non-small cell…
18 Apr 22
In the Phase 2/3 clinical trial in 140 children, a booster dose of Comirnaty has increased neutralizing antibodies…
05 Apr 22
AZD8233 is a novel, investigational ASO therapy designed to reduce blood cholesterol levels in patients with hypercholesterolemia (elevated…